| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-07 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 3e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.34 | 3e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |